These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34996385)

  • 1. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
    Yang X; Ai P; He X; Mo C; Zhang Y; Xu S; Lai Y; Qian Y; Xiao Q
    Mov Disord; 2022 Aug; 37(8):1634-1643. PubMed ID: 35607987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.
    Shin C; Lim Y; Lim H; Ahn TB
    Mov Disord; 2020 Jun; 35(6):1021-1027. PubMed ID: 32154946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
    Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.
    He X; Qian Y; Xu S; Zhang Y; Mo C; Guo W; Yang X; Xiao Q
    J Parkinsons Dis; 2021; 11(3):1167-1176. PubMed ID: 33935107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women.
    Skonieczna-Żydecka K; Grochans E; Maciejewska D; Szkup M; Schneider-Matyka D; Jurczak A; Łoniewski I; Kaczmarczyk M; Marlicz W; Czerwińska-Rogowska M; Pełka-Wysiecka J; Dec K; Stachowska E
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
    Chai L; Luo Q; Cai K; Wang K; Xu B
    BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments.
    Gao C; Li B; He Y; Huang P; Du J; He G; Zhang P; Tang H; Chen S
    CNS Neurosci Ther; 2023 Nov; 29(11):3657-3666. PubMed ID: 37144597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson's disease after dietary supplementation with branched-chain amino acids.
    Mi N; Ma L; Li X; Fu J; Bu X; Liu F; Yang F; Zhang Y; Yao L
    Open Med (Wars); 2023; 18(1):20230849. PubMed ID: 38045857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
    Chen J; Yao J; Wu Y; Chen Y; Mao C; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2412-6. PubMed ID: 25400045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and comparison of short chain fatty acids composition in gut diseases.
    Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
    World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.
    Duan WX; Wang F; Liu JY; Liu CF
    Neurosci Bull; 2024 Apr; 40(4):500-516. PubMed ID: 37755674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial.
    Becker A; Schmartz GP; Gröger L; Grammes N; Galata V; Philippeit H; Weiland J; Ludwig N; Meese E; Tierling S; Walter J; Schwiertz A; Spiegel J; Wagenpfeil G; Faßbender K; Keller A; Unger MM
    Genomics Proteomics Bioinformatics; 2022 Apr; 20(2):274-287. PubMed ID: 34839011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
    Du J; Zhang P; Tan Y; Gao C; Liu J; Huang M; Li H; Shen X; Huang P; Chen S
    Mov Disord; 2024 Aug; 39(8):1397-1402. PubMed ID: 38561921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.
    Kalyanaraman B; Cheng G; Hardy M
    Redox Biol; 2024 May; 71():103092. PubMed ID: 38377788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
    Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
    mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.